Tuesday, March 4, 2025
spot_img

AS Tallinna Vesi will hold an Investor Conference Webinar to introduce the results for the 4th quarter of 2024

AS Tallinna Vesi invites its shareholders, investors, analysts, and other stakeholders to join its investor conference webinar, introducing the results for the 4th quarter and 12 months of 2024.

The webinar is scheduled for 7 February 2025 at 10:00 am (EET) and will be held in English. The webinar will be hosted by Aleksandr Timofejev, Chief Executive Officer, and Taavi Gröön, Chief Financial Officer.

The questions will be answered by Aleksandr Timofejev and Taavi Gröön after the presentation. We encourage participants to send their questions before the webinar takes place, by 9:00 am (EET) on 7 February at the latest, to kommunikatsioon@tvesi.ee. Questions can also be asked during the webinar.

To join the webinar, please register via following link.

The registration will be open until 7 February at 9:00 am (EET). You will receive a link to the webinar.

The webinar will be recorded and made available online for everyone on the company’s website at www.tallinnavesi.ee and on AS Tallinna Vesi YouTube account.

Taavi Gröön
Chief Financial Officer
AS Tallinna Vesi
(372) 62 62 200
kommunikatsioon@tvesi.ee

Powered by SlickText.com

Hot this week

Quantum BioPharma ($QNTM): A Biopharma Company Amid Stock Manipulation Allegations

Quantum BioPharma Ltd. (NASDAQ: QNTM, CSE: QNTM, FRA: 0K91),...

Form 8.3 – Warehouse REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Assura Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Verb to Acquire AI Social Selling Startup LyveCom

Deal Positions VERB’s MARKET.live As One Of The Industry’s...

KBS Builders Wins Two Large Commercial Contracts Totaling $5.2 Million for Multifamily Construction Projects in Maine

Star Announces Preliminary Key Financial Metrics for Q4 2024OLD...

Topics

Quantum BioPharma ($QNTM): A Biopharma Company Amid Stock Manipulation Allegations

Quantum BioPharma Ltd. (NASDAQ: QNTM, CSE: QNTM, FRA: 0K91),...

Form 8.3 – Warehouse REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Form 8.3 – Assura Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A...

Verb to Acquire AI Social Selling Startup LyveCom

Deal Positions VERB’s MARKET.live As One Of The Industry’s...

MIND CTI Reports Fourth Quarter and Full Year 2024 Results

* Board Declares Cash Dividend* MIND CTI to Host...
spot_img

Related Articles

Popular Categories

spot_img